TABLE 3.
Antibiotic susceptibility profiles determined by the agar diffusion method for mecA-positive MRSA isolates
| Isolatea | Susceptibilityb
|
Antibiotype | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AN | AM | FOX | CF | CIP | CC | E | GM | IM | K | NOR | OFX | P | TE | SXT | ||
| 1 | S | R | R | R | S | R | R | S | S | S | S | S | R | S | S | A |
| 2 | S | R | S | R | S | S | S | R | S | R | S | S | R | R | S | B |
| 3 | S | R | R | R | S | R | R | S | S | S | S | S | R | S | S | A |
| 4 | S | R | R | R | S | R | R | S | S | S | S | S | R | S | S | A |
| 5 | S | R | S | R | S | S | S | R | S | R | S | S | R | R | S | B |
| 6 | S | R | R | R | R | R | S | R | R | R | S | S | R | R | S | C |
| 7 | S | R | R | R | R | R | R | R | R | R | R | R | R | R | S | D |
| 8 | S | R | R | S | S | R | R | R | S | R | S | R | R | S | S | E |
| 9 | S | R | R | R | S | R | R | R | R | R | S | S | R | S | S | F |
| 10 | S | R | S | R | S | S | R | R | S | R | S | S | R | S | S | G |
| 11 | S | R | S | S | S | S | R | R | S | R | S | S | R | S | S | H |
| 12 | S | R | S | S | S | S | R | R | S | R | S | S | R | S | S | H |
| 13 | S | R | R | R | S | R | R | R | R | R | S | S | R | S | S | F |
| 14 | S | R | R | R | R | R | R | R | R | R | S | S | R | R | S | C |
| 15 | S | R | S | S | S | S | S | S | S | S | S | S | R | S | S | I |
| 16 | S | R | R | R | S | R | S | S | S | S | S | S | R | R | S | J |
| 17 | S | R | R | R | R | R | R | R | R | R | R | R | R | R | S | D |
| 18 | S | R | R | R | S | S | R | R | S | R | S | S | R | R | S | K |
| 19 | S | R | S | R | S | S | S | R | S | R | S | S | R | R | S | B |
a
Isolate numbers are in accordance with those in Table 2.
b
Abbreviations: AN, amikacin; AM, ampicillin; FOX, cefoxitin; CF, cephalothin; CIP, ciprofloxacin; CC, clindamycin; E, erythromycin; GM, gentamicin; IM, imipenem; K, kanamycin; NOR, norfloxacin; OFX, ofloxacin; P, penicillin; TE, tetracycline; SXT, trimethoprim-sulfamethoxazole; S, susceptible; R, resistant.